Industry News | News List

AbbVie's oral JAK inhibitor Rinvoq (upatinib) approved by NMPA
2022-03-11

AbbVie recently announced that China’s National Medical Products Administration (NMPA) has approved

Genentech’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-Symptomatic Babies Under 2 Months of Age With Spinal Muscular Atrophy (SMA)
2022-02-11

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (

Novartis' asciminib bests Pfizer's Bosulif in phase 3 leukemia trial
2021-11-02

Novartis’ asciminib hasoutperformedPfizer’s Bosulif in a phase 3 chronic myeloid leukemia (CML) stud

Hengrui announces new drug SHR7280
2021-10-16

On October 11, 2021, Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that SHR0302, for the treat

Novartis secures new approval in China for Cosentyx® (secukinumab) in pediatric psoriasis
2021-08-23

August 17, 2021 – Novartis today announced that the China National Medical Products Administration (

USFDA approves KIT inhibitor Ayvakit (Avatinib)
2021-06-25

CStone's partner Blueprint Medicines recently announced that the U.S. Food and Drug Administrati

Xofluza was approved in China
2021-05-13

On April 29, 2021, Roche China announced that its innovative influenza drug Xofluza® (Mabaloxavir) h

Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI
2021-03-15

Gilead Sciences, Inc. (Nasdaq: GILD) today presented additional results from the Phase 2/3 CAPELLA t

BeiGene Announces EMA Acceptance of its Marketing Authorization Application for BRUKINSA® (Zanubrutinib) for the Treatment of Patients with WM
2021-02-25

On June 18, 2020, BeiGene, Ltd. (“BeiGene” or the “Company”), a commercial-stage biotechnology compa